No Data
No Data
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Raises Target Price to $4
Barclays Reaffirms Their Hold Rating on Pacific Biosciences (PACB)
Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ...
Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript Summary
Pacific Biosciences Of California, Inc. Q3 Loss Decreases, Beats Estimates